King Pharmaceuticals, Inc. v. Sandoz Inc.

U.S. Court of Appeals for the Federal Circuit

King Pharmaceuticals, Inc. v. Sandoz Inc.

Opinion

NOTE: ThiS order is n0npreceden1;ia1. United States Court of AppeaIs for the FederaI Circuit KING PHARMACEUTICALS, INC. AND KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC., Plaintiffs-Appellants, and PHARMACEUTICAL IP HOLDING, INC., Plaintiff-Appellant, V. SANDOZ INC., Defendant~Appellee. 2011-1227 Appea1 from the United States DiStrict C0urt for the District of New Jersey in case n0. 08-CV-5974, Chief Judge Garre-tt E. Br0wn, Jr. ON MOTION ORDER

KING PHARMA V. SANDOZ 2 Pharmaceutica1 IP Holding, Inc. moves for a 30-day extension of time, until l\/lay 25, 2011, for the appellants to file their initial briefs, for a 30-day extension of time, until August 3, 2011, for the appellee to file its response brief, for a 7 -day extension of tin1e, until August 24, 2011, for the appellants to file their reply briefs, and for an extension of time, until August 31, 2011, to file the joint appendix Upon consideration thereof IT ls ORDERE1) THAT: The motion is granted FOR THE COURT |‘1AR 2 4 2911 /S/ Jan H0rba1y Date J an Horbaly Clerk cc: Cha1'les M. Lizza, Esq. Martir1 B. Pavane, Esq. Michelle S. Rhyu, Esq. ruin v.s. count 0 PEALs rex S21 me reuse-iA'i.PcrRcun MAR 24 2011 .|ANHDRBAL¥ eC|.EIl(

Reference

Status
Unpublished